Published in World J Gastroenterol on June 28, 2014
Management of patients with hepatitis C infection and renal disease. World J Hepatol (2015) 0.95
Granulomatous interstitial nephritis. Clin Kidney J (2015) 0.91
Hepatitis C virus: Virology, diagnosis and treatment. World J Hepatol (2015) 0.89
Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatol Int (2015) 0.84
Hepatitis C and kidney disease: An overview and approach to management. World J Hepatol (2015) 0.83
Membranous nephropathy associated with hepatitis C virus infection treated with corticosteroids and Ledipasvir-Sofosbuvir: a case report and review of literature. Oncotarget (2017) 0.75
Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis. World J Gastroenterol (2016) 0.75
Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-acting Antivirals. Curr Hepatol Rep (2016) 0.75
Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS). Dig Dis Sci (2016) 0.75
Hepatitis C virus-associated cryoglobulinemia with membrano-proliferative glomerulonephritis treated with prednisolone and interferon: A case report. Exp Ther Med (2017) 0.75
Diagnosis, management, and treatment of hepatitis C: an update. Hepatology (2009) 22.53
Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol (2001) 18.80
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med (2004) 16.21
Diagnosis, management, and treatment of hepatitis C. Hepatology (2004) 11.62
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med (2011) 4.39
Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology (2004) 4.16
Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir. Hepatology (2013) 3.68
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51
KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl (2008) 3.00
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. Ann Rheum Dis (2013) 2.99
Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med (1980) 2.87
Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol (2004) 2.81
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology (2003) 2.76
Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis (1993) 2.69
Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) (2000) 2.35
TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol (2008) 2.23
Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology (1999) 2.11
Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med (1992) 2.03
Glomerulonephritis. Lancet (2005) 1.81
Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum (1999) 1.77
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A (2005) 1.76
Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford) (2006) 1.74
Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology (1997) 1.71
Relationship between hepatitis C and microalbuminuria: results from the NHANES III. Kidney Int (2005) 1.71
Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology (2003) 1.70
Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med (2006) 1.68
Hepatitis C and renal disease: an update. Am J Kidney Dis (2003) 1.65
Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood (2010) 1.64
Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients. Arthritis Rheum (2009) 1.64
Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol (2006) 1.61
Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med (1998) 1.61
Hepatitis C virus and kidney disease. J Hepatol (2008) 1.61
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology (1997) 1.55
Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. Arthritis Rheum (2009) 1.55
Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol (1986) 1.50
Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis (1996) 1.47
Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med (2007) 1.45
Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol (2009) 1.45
Extrahepatic manifestations of chronic HCV infection. J Gastrointestin Liver Dis (2007) 1.37
Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol (2004) 1.30
The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS (2008) 1.30
Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol (2006) 1.28
The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat (2007) 1.27
Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol (2004) 1.19
Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol (2007) 1.18
Management of hepatitis C virus-related mixed cryoglobulinemia. Am J Med (2010) 1.17
Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) (2001) 1.17
Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms. Am J Kidney Dis (2008) 1.17
Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. Am J Kidney Dis (1999) 1.16
Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study. Am J Kidney Dis (2010) 1.15
Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis (2004) 1.14
Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant (2004) 1.13
Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol (2006) 1.13
Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis. Curr Opin Rheumatol (2008) 1.13
Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. N Engl J Med (2013) 1.09
Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol (1995) 1.08
Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant (2005) 1.08
Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis (2007) 1.08
Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant (2007) 1.07
Hepatitis C is a predictor of poorer renal survival in diabetic patients. Diabetes Care (2005) 1.06
Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link? J Intern Med (2006) 1.06
Fibrillary glomerulopathy. Kidney Int (1998) 1.04
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant (2003) 1.04
Increased frequency of HCV but not HBV infection in type 2 diabetic patients in Turkey. Int J Clin Pract (2002) 1.03
Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Am J Kidney Dis (2012) 1.03
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant (2003) 1.03
The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) (2002) 1.03
Hepatitis C virus-related kidney disease: an overview. Clin Nephrol (2008) 0.99
Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol (1999) 0.97
Mixed IgG-IgM cryoglobulinemia with glomerulonephritis. Immunochemical, fluorescent and ultrastructural study of kidney and in vitro cryoprecipitate. Am J Med (1975) 0.96
Crescentic fibrillary glomerulonephritis associated with hepatitis C viral infection. Clin Nephrol (2003) 0.96
Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol (2008) 0.95
Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation (1997) 0.94
Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol (1998) 0.93
Pegylated interferon-alpha-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study. Transpl Int (2009) 0.93
Transplantation in the patient with hepatitis C. J Am Soc Nephrol (2000) 0.93
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Hepatology (2001) 0.91
Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Am J Kidney Dis (1995) 0.90
Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. J Am Soc Nephrol (2004) 0.90
Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant (2001) 0.90
Hepatitis C antibody status and outcomes in renal transplant recipients. Transplantation (2001) 0.90
De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation (1995) 0.89
Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation. Transplantation (1998) 0.89
High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol (2000) 0.89
Detection of virus-like particles in liver biopsies from HCV-infected patients. Res Virol (1999) 0.88
Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients. Transplantation (2002) 0.87
Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity. Arthritis Rheum (1999) 0.87
Focal segmental glomerular sclerosis among patients infected with hepatitis C virus. Nephron (1999) 0.86
IgA nephropathy associated with hepatitis C virus infection. Nephron (1995) 0.84
Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant (2002) 0.82
Hepatitis C virus RNA in kidney biopsies from infected patients with renal diseases. J Viral Hepat (2000) 0.82
Liver damage in hemodialysis patients with hepatitis C virus viremia: a prospective 10-year study. Dig Dis Sci (2000) 0.82
Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant (2002) 0.81
Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritis. Nephrol Dial Transplant (1996) 0.81
Hepatitis C associated glomerulonephritis. Am J Nephrol (1995) 0.81